Clinical Trial Update: Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing cryoapplication to anti-VEGF before diabetic vitrectomy is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy
• Tractional Retinal Detachment
• Vitreous Hemorrhage

Drugs mentioned

• Cryoapplication
• anti-VEGF (vascular endothelial growth factor inhibitor)

Snippet

Sponsor: Khairallah Moncef | Conditions: Proliferative Diabetic Retinopathy, Vitreous Hemorrhage | Phase 4 | Status: UNKNOWN